| Literature DB >> 31938584 |
Merin Jose1, Saba Amir1, Rajesh Desai1.
Abstract
Sheehan's syndrome is hypopituitarism due to pituitary gland necrosis resulting from hemorrhagic shock during pregnancy. It is a rare complication with varied manifestations and a considerable delay in diagnosis. We describe the case of a 36-year-old female with eight years of non-specific symptoms of generalized myalgias and intense fatigue managed symptomatically all these years. Further clinical assessment revealed amenorrhea and agalactia ongoing for several years without a clinical diagnosis. A good history and physical led to the diagnosis during a routine outpatient visit. She had significant improvement noted following the commencement of treatment. Previous case reports describe cases being diagnosed after one or other complications from long-term panhypopituitarism. Through this case, we want to illustrate that undiagnosed Sheehan's syndrome is associated with long-term morbidity, and there should be a high index of suspicion for it to be diagnosed during a routine clinical visit and thus prevent complications before a diagnosis can be made. It is essential to create awareness, especially in developed countries like the United States, where it has received less attention over the last few years.Entities:
Keywords: adrenal insufficiency; amenorrhea; case report; central hypothyroidism; chronic; delay in diagnosis; fatigue; hypothyroidism; panhypopituitarism; sheehan's syndrome
Year: 2019 PMID: 31938584 PMCID: PMC6942501 DOI: 10.7759/cureus.6290
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1Clinical findings on presentation and changes with treatment
a) loss of lateral one-third of the eyebrows at the time of diagnosis; b) hands at the time of diagnosis; c) slight decrease in the puffiness of the hands after two weeks of treatment; d) hands after six weeks of treatment
Significant/Abnormal Laboratory Results
Significant laboratory results (SN 1 - 8) confirming panhypopituitarism; SN 9 - 15: other abnormal and significant laboratory results of the patient
L: lymphocytes; N: neutrophils
| SN | Parameter | Patient’s blood level | Reference range | |
| 1 | Thyroid-stimulating hormone | 0.746 uIU/mL | 0.465 - 4.68 uIU/mL | |
| 2 | Triiodothyronine | 0.56 ng/mL | 0.97 - 1.69 ng/mL | |
| 3 | Tetraiodothyronine or thyroxine | < 0.25 ng/dL | 0.79 - 2.35 ng/dL | |
| 4 | Cortisol | < 0.4 mcg/dL | 4.5 - 22.7 mcg/dL | |
| 5 | Luteinizing hormone | < 0.20 mIU/mL | 0.5 - 76.3 mIU/mL | |
| 6 | Follicular stimulating hormone | 1.6 m IU/mL | 2.5 - 116 IU/mL | |
| 7 | Prolactin | < 1 ng/ml | 3.0 - 30.0 ng/ml | |
| 8 | Creatinine kinase | 1,538 µ/L | 30.0 - 135.0 µ/L | |
| 9 | Somatomedin | < 16 ng/ ml ng/mL | 53 - 331 ng/mL | |
| 10 | White blood cell count (differential) | 6.8 (N - 33%, L - 62%) x 103/mm3 | 4.0 - 11.0 x 103/mm3 | |
| 11 | Serum sodium | 132 mmol/L | 136 - 145 mmol/L | |
| 12 | Alkaline phosphatase | 144 µ/L | 42 - 98 µ/L | |
| 13 | Aspartate aminotransferase | 108 µ/L | 14 - 36 µ/L | |
| 14 | Alanine aminotransferase | 42 µ/L | 9 - 52 µ/L | |
| 15 | Total bilirubin | 1.3 mg/dL | 0.1 - 1.2 mg/dL | |
| 16 | Vitamin D | 10 ng/mL | 25 - 80 ng/mL | |
| 17 | C-reactive protein, rheumatoid factor, antinuclear antibodies | Normal | NA | |
Figure 2Magnetic resonance imaging (MRI) of the brain showing an empty sella